BRONCHO-VAXOM

This brand name is authorized in Austria, Brazil, Ecuador, Poland, Romania, Turkey

Active ingredients

The drug BRONCHO-VAXOM contains one active pharmaceutical ingredient (API):

1 Lyophilized bacterial lysate

Bacterial lysates are powerful inducers of a specific locoregional immune response that significantly enhance the concentration of antibodies directed to antigenic structures of bacteria most commonly observed during infections of the upper respiratory tract. Read about Bacterial lysates

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AX	Other therapeutic products	V Various → V03 All other therapeutic products → V03A All other therapeutic products
Discover more medicines within V03AX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501100501117415, 501100502113413, 501100503111414, 501100504132415, 508521060013217, 508521060013317, 508521060013417, 508521060013517
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 16.356-3-10-06, 16.357-3-10-06, 25.839-08-04
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100011710, 100222654, 100230524, 100255694, 100255702, 100277827, 100277885, 100387272, 100387289, 100438130, 100438160, 100443289, 100443639, 100443680, 100443792, 100468118
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68628001, W68628002, W68629001, W68629002, W68630001, W68630002
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699708151583, 8699708151590